Skip to content

Inter-observer Variation in Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET CT

Inter-observer Variation in Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET CT

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05611658
Enrollment
23
Registered
2022-11-10
Start date
2020-05-20
Completion date
2023-09-30
Last updated
2024-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Brief summary

The aim of the study is to investigate inter-observer variation in gross tumor volume (GTV) delineation of oesophageal cancer on different imaging modalities - CT, PET CT and MR.Twenty-three consecutive patients with esophageal cancer treated with preoperative or curative chemoradiotherapy were selected. All patients had CT, PET CT and MR imaging in treatment position prior to radiotherapy.Five experienced observers from our institution will independently delineate GTV on CT alone, MR alone, PET CT alone, on co-registered CT and MR and co-registered PET CT and MR. Inter-observer agreement, expressed in generalized conformity index (CIgen) and mean volumes of GTV will be calculated per patient and imaging modality.

Interventions

OTHERMR, PET CT

diagnostic method

Sponsors

Institute of Oncology Ljubljana
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* locally advanced esophageal cancer eligible for treatment with preoperative or curative chemoradiotherapy

Exclusion criteria

* contraindications for MR

Design outcomes

Primary

MeasureTime frameDescription
Change of interobserver variability in target volume delineation on CT, PET CT and MR.Through study completion, an average of 1 year.To compare target volume delineation of esophageal cancer using CT, PET CT and MR with determining generalized conformity indexes and mean volumes of GTV.

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026